Erasca (ERAS) Touches 3-Year High as 4 Analysts Go Bullish; Gets 267% PT Hike

Core Viewpoint - Erasca Inc. (NASDAQ:ERAS) has reached a three-year high, driven by bullish outlooks from multiple investment firms, with a notable price target upgrade of up to 267 percent [1][4]. Group 1: Stock Performance - Erasca Inc. achieved a record high of $9.72 during intra-day trading, closing at $9.56, reflecting a 15.04 percent increase [2]. - The stock's rally was supported by positive coverage from analysts at Clear Street, HC Wainwright, Piper Sandler, and Stifel, who issued "buy" and "overweight" ratings [2]. Group 2: Analyst Ratings and Price Targets - Clear Street raised its price target for Erasca by 267 percent to $11 from $3, maintaining a "buy" recommendation [3]. - HC Wainwright increased its price target to $11 from $6, also with a "buy" recommendation, following positive preliminary results from the clinical study of ERAS-0015 [4]. - Stifel set a new price target of $10, up from $6, while maintaining a "buy" recommendation [5]. - Piper Sandler initiated coverage with an "overweight" rating but set a lower price target of $5 [5].